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ABSTRACT 
Background: Breast cancer is the second largest cancer in the world.The gold standard for breast 
cancer diagnosis and prognosis is grade assessment (mitotic, nuclear pleiomorphism, tubular 
formation), based on breast tissue histopathology. However, this assessment has limitation in that it 
is subjective and semi quantitative. A genetic biomarker known as  microRNA (miRNA) may 
regulate human gene expression by targetting mRNA. One of the miRNA, i.e. miR-21, is able to 
suppress tumor suppressor mRNA, resulting in increased cellular proliferation andneoplastic 
transformation, and decreased apoptosis. This study aimed to investigate the expression of miR-21in 
breast cancer with histopathologic grade I, II, and III. 
Subjects and Method: This was a descriptive study with cross-sectional design involving paraffin 
block (FFPE) samples of ductal-type breast cancer tissue. Sixty four samples were obtained from the 
department of Anatomical Pathology, Haji Adam Malik Hospital, Medan. Patients history were 
obtained through medical records followed by sample processing (Total RNA Isolation, cDNA 
Synthesis, and Examination of miR-21 Expression using Real-Time qPCR). MiR-21 expression from 
every hystopathologic grade was obtained using Fold Change Calculation. 
Results: Breast cancer occurred more frequently in age group of 30-49 years old. Based on the 
histopathologic grade, most breast cancer was found in grade II. Analysis of miR-21 expression 
showed that miR-21 expression was higher in grade III compared to other grade. 
Conclusion: Breast cancer occured more frequently in the productive age group.Most breast 
cancer were found in grade II. Increased miR-21 expression in grade III may suggest that miR-21 is 
an oncomiR, which plays an important role in the development of malignant breast cancer. 
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BACKGROUND 
 
Breast cancer is the second most common 
cancer in the world (Ferlay et al., 2010; 
Kementerian Kesehatan Indonesia, 2013). 
According to the data from Haji Adam 
Malik Central Hospital, Medan, Indonesia, 
there were 200 new patients diagnosed with 
breast cancer during 2012. Histopathology 
examination of breast tissue is a Gold Stan-
dard for the diagnosis enforcement, and 
also for prognosis prediction through histo-
pathology grade. Histopathology is an ass-
essment toward the degree of cancer 
differentiation (cell mitosis, pleomorphism 
of cell nucleus, and tubulus formation), 
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which is related to patients’ prognosis pre-
diction (Tavassoli and Deville, 2003; 
Malhotra et al., 2010). The assessment 
method is already commonly used (Rakha et 
al, 2010), however it has limitation since it 
is subjective and semi quantitative. There-
fore other more objective biomarkers are 
needed to complement prognosis. A relati-
vely potential biomarker of breast cancer 
which is also frequently investigated 
currently is microRNA. 
MicroRNA (MiRNA) is a non-coding 
endogen RNA with 18-22 nucleotides in 
length, and also plays an important role in 
the regulation of gene expression. MiRNA 
works by degrading or impeding the trans-
lation of mRNA target; so that miRNA is 
able to influence protein expression (Calin 
and Croce, 2006; Cho, 2007), including 
protein which acts in the development of 
breast cancer. MicroRNA-21 (miR-21) is a 
micro RNA which experience increasing 
expression in breast cancer, by suppressing 
or impeding protein translation of tumor 
suppressor (Ioro et al, 2005). It results in 
the uncontrolled cell proliferation (can be 
assessed through grading component that is 
cell mitosis calculation). The excessive ex-
pression of miR-21 in breast cancer patients 
is suspected to be related with poor prog-
nosis (Lee et al., 2011). 
In Indonesia study on microRNA and 
its association with cancer is still very few, 
therefore this study aims to investigate the 
expression of miR-21 toward histopathology 
of patients’ breast cancer tissue, especially 
in the city of Medan, Indonesia. 
 
SUBJECTS AND METHOD 
 
Research license has been obtained fro the 
Committee of Research Ethics of Faculty of 
Medicine, University of North Sumatra Me-
dan Indonesia. The research design was 
cross sectional. The type was descriptive. 
The subject used was paraffin block (FFPE) 
of invasive ductal breast cancer tissue, with 
64 subjects obtained from Pathology Ana-
tomy Department of Haji Adam Malik Hos-
pital Medan. Subject determination was 
conducted in purposive sampling, helped by 
Pathological Anatomist. The studied vari-
able was the expression of miR-21 (inde-
pendent) and the histopathology grade of 
breast cancer tissue (dependent). Data of 
research subject sampling was conducted in 
Haji Adam Malik Hospital Medan. The 
grade assessment was obtained from medic-
al records data of breast cancer patients. 
miR-21 examination was conducted in 
Molecular Biology Laboratory of Faculty of 
Medicine UGM, through phases of RNA 
isolation from FFPE subject, examination 
on RNA concentration, cDNA synthesis, and 
analysis on miR-21 expression by using Real 
Time qPCR. Using Fold Change formulat-
ion, miR-21 was obtained in every grade of 
histopathology, subsequently, normality test 
and descriptive analysis were conducted. 
Total RNA Isolation of Paraffin Block 
(FFPE) 
Paraffin block was sliced by using micro-
tome with 7 μm of thickness, afterwards it 
was put into 1.5 ml centrifuge tube. The 
Total RNA isolation process was conducted 
based on the manual of TiangenRNAprep 
Pure FFPE kit. Transfer 1ml of Xylene into 
the tube, vortexed and centrifuged at 12.000 
rpm, afterward, supernatant was aspirated 
and disposed. Insert 1ml of ethanol, using 
similar phase as Xylene. Dry the pellet of 
ethanol. Insert buffer and proteinase K into 
the tube and vortexed. The tube was incu-
bated in temperature 55o C and 80o C. The 
tube was centrifuged and supernatant was 
transferred into new tube. Buffer was put 
inside new tube, and vortexed. Ethanol was 
added into the tube, and vortexed. The 
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mixture was transferred into Spin Column 
CR3, and centrifuged, afterward the liquid 
inside the tube was disposed. DNAse I 
solution was prepared, and put inside Spin 
Column CR3, then incubated for 15 minutes. 
Buffer RW1 was put inside Spin Column 
CR3, centrifuged, and disposed the liquid 
inside the tube. Insert buffer RW into Spin 
Column CR3, incubated for 2 minutes, 
centrifuged and disposed the liquid inside 
the tube. Collection tube was centrifuged for 
2 minutes, and disposed the liquid inside 
the tube. Spin Column CR3 membrane was 
dried up. Spin Column CR3 was put in a 
new centrifuge tube, put RNAse-freeH2O 
into membrane. The tube was closed, 
incubated and centrifuged until total RNS 
was obtained. The centrifuge tube with RNA 
Total inside and the tube were closed, and 
put inside refrigerator. Subsequently, total 
RNS concentration was examined by using 
NanoDrop Spectrophotometer. 
CDNA Syntesis of Total RNA 
The materials used were RNA sample, 
Reaction Buffer, Nuclease-Free Water, 
Spike in (UniSp6, as internal control), and 
Mixed Enzyme. The steps were conducted 
based on the manual cDNA synthesis kit 
from miRCURY LNATM Universal RT 
microRNA PCR (Exiqon). RNA sample was 
slowly defrosted in room temperature, 
vortexed, and spun-down. Removed 5x 
Reaction Buffer, Nuclease-free water and 
Spike in (UniSp6) from refrigerator, de-
frosted in room temperature, vortexed and 
spun-down. Removed Mix Enzyme from 
refrigerator to be homogenized, to make 
Master Mix, after ward it was vortexed and 
spun-down. Master Mix was distributed to 
every PCR tube, then RNA sample was 
inserted into PCR tube, and spun-down. 
PCR tube subsequently was put inside RT-
PCR instrument, operate it according to its 
program. cDNS result was finally stored 
within refrigerator. 
Analysis miR-21 with Qrt-PCR 
The materials used were cDNA, SYBR Green 
Master Mix, primary miR-21 (has-miR-21), 
and primary UniSp6. The steps were 
conducted based on the manual kit from 
miRCURY LNATM Universal RT microRNA 
PCR (Exiqon). cDNA was defrosted slowly 
in room temperature, vortexed, and spun-
down. cDNA was diluted in advance inside 
1.5ml centrifuge tube, vontexed, and then 
spun-down. Removed SYBR Green Master 
Mix, Primary set miR-21 and Primary Spike 
in (UniSp6) from refrigerator to be homo-
genized by being thawed and vortexed to 
make Master Mix for has-miR-21 and Spike 
in control. The Master Mix was put into 
every qPCR tube, and then added with 
cDNA sample. Every tube was labeled and 
put into qRT-PCR machine, set the program 
into Real Time qPCR, and operate it 
according to its program. 
Statistical Analysis 
The data obtained is in a form of miR-21 
expression (based on Fold Change formula 
from the obtained value of Cq miR-21 and 
UniSp6 by using qRT-PCR), and followed by 
conducting normality test, Kolmogorov-
Smirnov and descriptive analysis. 
 
RESULTS 
 
A descriptive analysis research had been 
conducted on the description of miR-21 ex-
pression toward histopathology grade of 
breast cancer, by using 64 subjects of paraf-
fin block (FFPE) of invasive ductal type 
breast cancer tissue. Data analysis was 
conducted as follow: 
A. Characteristics of Research Subjects 
Table 1 presents the characteristics of re-
search subjects obtained based on the age. It 
can be observed from Table 1 that the 
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research subjects are mostly come from age 
group 30-49 year old which is 36 subjects 
(56.30%), compared to age group of 50-78 
year old.  
 
Table 1. Distribution of research subjects based on age group 
Age Groups 
(Year) 
Diagnose 
Total 
Grade I Grade II Grade III 
n % n % n % n % 
30 – 49 6 40.00 28 73.70 2 18.20 36 56.30 
50 – 78 9 60.00 10 26.30 9 81.80 28 43.80 
Total 15 100 38 100 11 100 64 100 
 
B. Proportion of Histopathology Grade 
of Research Subjects 
According to the entire research subject, 
proportion of each histopathology grade of 
breast cancer was obtained as it is seen in 
the following picture 1: 
 
 
 
 
 
 
 
 
 
 
 
Picture 1. Proportion of 
histopathology grade of breast  
cancer of research subjects 
 
From Picture 1, it can be observed that 
the biggest proportion comes from grade ii 
which is 38 subjects (59.4%), meanwhile the 
smallest proportion is grade III which 11 
subjects (17.2%).  
C. Measuring miR-21 Expression in 
Breast Cancer Tissue of Research 
Subjects  
miR-21 expression  was measured by using 
qRT-PCR instrument, it was conducted to 
the entire research subjects. Based on the 
value of Cq miR-21 and UniSp6 from qRt-
PCR, the value was put into Fold Change 
Formula (2-∆Cq) and obtained miR-21 
expression data. Data normality test and 
descriptive test were conducted toward the 
data as it is presented in Table 2. 
From Table 2 it can be found out that 
miR-21 expression data is distributed nor-
mally. The average of miR-21 expression 
was obtained from the result of descriptive 
test, and miR-21 expression in grade III is 
the highest that is -0.49 ± 1.28. Whereas, 
the average of miR-21 expression on grade 
II is the lowest that is -0.86 ± 1.09. The 
average of miR-21 expression in grade I is as 
much as -0.66  ± 1.45. 
Table 2. MiR-21 expression toward histopathology grade of breast cancer 
 
Diagnose 
 
miR-21 
p 
Median Mean SD 
95% CI  
Lower Upper 
Grade I -0.29 -0.66 1.45 -1.46 0.14 0.200 
Grade II -1.11 -0.86 1.09 -1.21 -0.49 
Grade III -0.51 -0.49 1.28 -1.35 -0.37 
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DISCUSSION 
In this research, the number of breast 
cancer patients who came from 30-49 year 
age group were a lot more than those who 
came from 50-78 year age group. It was 
estimated as the impact of the exposure of 
estrogen or progesterone hormone toward 
breast tissue, since the beginning of mens-
truation up to menopause (Hulka and 
Moorman, 2001). The onset during first 
menstruation and during menopause influ-
ences the period of hormone exposure. Pro-
liferation of breast epithelia can be induced 
by estrogen (Aguas et al., 2005), and its 
active form that is estradiol (E2) can trigger 
the process of neoplastic transformation on 
human breast epithelia (Russo et al., 2006; 
Fernandez et al., 2009). 
In post-menopause women, breast 
cancer is estimated influenced by estrogen 
synthesis which is related to adiposity. Du-
ring menopause, ovaries no longer can 
produce estrogen hormone. Estrogen is ob-
tained from androgenic precursors of adren-
al glands which experience aromatization to 
become estrogen in adipose tissue (Kluttig 
and Pokrzywnak, 2009). Menopause wo-
men with obesity are having a high risk to 
suffer from breast cancer as the impact of 
high level of estrogen especially estradiol 
(Hulka and Moorman, 2001; Key et al., 
2003). Based on the research conducted by  
McTiernan et al., (2003), the increas-
ing estrone and estradiol was found along 
with the increasing parameter of adiposity. 
In post-menopause women with obesity and 
breast cancer, there are is increasing para-
meter of adiposity which is related to the 
increasing level of hormones that cause 
tumor. 
The proportion of histopathology gra-
de of the research subjects showed the most 
proportions came from grade II (59.44%), 
followed by grade I (23.44%), and the 
smallest proportion came from grade III 
(17.20%). It was similar with the study 
made by Yan et al., (2008), however it was 
different with the study made by Qian et al., 
(2009) where the most proportion came 
from grade III and the smallest was from 
grade I. 
An analysis on miR-21 expression to-
ward the entire research sample was con-
ducted. Based on the comparison of average 
miR-21 expressions between grade, it was 
obtained that the highest miR-21 expression 
came from grade III, followed by grade I 
and the lowest expression was from grade 
II. The increasing expression of miR-21 in 
grade III from the research result was in 
accordance with the research result of Qian 
et al., (2009) and Lee et al., (2011). 
A soaring MiR-21 expression in grade 
III caused an increasing regulation in a form 
of translation or degradation pressure by 
miR-21 toward tumor mRNA target tumor 
suppressor (among others are Network p53 
and PDCD4 (Chen et al, 2012). Consequent-
ly, the function of tumor suppressor protein 
was extremely decreasing in term of control 
on cell proliferation and neoplastic trans-
formation. The process of cell proliferation, 
cell differentiation, and neoplastic transfor-
mation kept on going and it was hard to 
control. The impact was seen from the 
description of grade III which were ex-
tensively varied formation of tubulus and 
nuclear pleomorphism, as well as excessive-
ly increasing cell mitosis, compared to grade 
I and II. 
Otherwise, low expression of miR-21 
in grade I and II caused regulation effect of 
miR-21 toward Mrna target tumor suppress-
or was also low. Consequently, cell proli-
feration and neoplastic transformation were 
still in control by tumor suppressor protein. 
It was in accordance with the description of 
grade I and II, which was the formation 
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pattern of tubulus, nuclear pleomorphism, 
and cell mitosis relatively close to the 
description of normal breast tissue. 
MiR-21 is known to have some target 
mRNA tumor suppressor, among others are 
PDCD4 and Network of p53 (Frankel et al., 
2008; Papagiannakopoulos et al., 2008). 
PDCD4 is tumor suppressor protein which 
functions to control cell transformation 
process, is able to hamper c-Jun and AP-1 
transactivation so that malignancy progress-
ivity can be lowered (Yang et al., 2001; 
Bitomsky et al., 2004; Jansen et al., 2005). 
Frankel et al., (2008) found that mRNA 
PDCD4 could be hampered by miR-21. If 
miR-21 suppressed PDCD4 expression, thus 
would impact in the increasing of cell proli-
feration and transformation. 
In addition to PDCD4, another tumor 
suppressor is p53 that functions to minim-
ize genetic breakdown so that carcino-
genetic process can be prevented. Abnormal 
cell proliferation can be controlled through 
cycle cell arrest or apoptosis, it depends on 
the level of DNA breakdown. In doing its 
functions, p53 protein needs other protein 
to help stabilizing and activating p53. The 
proteins meant are among others HNRPK 
(Moumen et al., 2005), DAXX (Li et al., 
2007), TOPORS (Lin et al., 2005). MiR-21 
can suppress protein expression which is 
important for stabilization and activation of 
p53 as well as proteins which become the 
target of p53 transcription (Papagiannako-
poulos et al., 2008). The hampered protein 
expression by miR-21, will impact in the 
increasing of cell proliferation and the 
decreasing of apoptosis. 
Breast cancer is suffered more by pro-
ductive age group, and grade II is the largest 
proportion of histopathology grade. By find-
ing an escalating miR-21 in grade III (com-
pared to grade I and II), it is even more 
confirming the assumption that miR-21 is 
an oncomiR which plays an important role 
in the process of malignancy development 
on breast cancer. 
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